The US FDA Acts To Bolster Adverse Event Reporting For Compounded Drugs

 
• By Joanne S. Eglovitch
  
Clipboard with medical form and sign Hormone Replacement Therapy. - Image
FDA Wants Drug Compounding Pharmacies To Up Their Adverse Reporting Game • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance